The PillCam SB has been cleared since 2001 for the visualization of the small bowel mucosa and may be used as a tool in the detection of abnormalities of the small bowel in adults and children. The updated FDA approval supports the use of PillCam for the visualization of lesions in a variety of important conditions, such as Crohn’s disease, iron deficiency anemia and obscure gastrointestinal bleeding.
Read the news release about PillCam SB.
Read other coverage about GI devices:
– Healthmark Industries Announces Availability of Product to Help Ensure Safe Endoscope Storage
– Mayo Clinic Gastroenterologist Details Role of Endoscopic Imaging in Small Bowel
– Use of NSAIDs Should be Determined Before Interpreting Capsule Endoscopy Findings
